Cargando…

Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature

Four patients, from three families, with alkaptonuria receiving 4‐hydroxyphenylpyruvate dioxygenase‐inhibiting nitisinone therapy, which lowers homogentisic acid and increases tyrosine, developed vitiligo. Three of the four patients were receiving nitisinone 2 mg daily, while the fourth was on 10 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranganath, Lakshminarayan, Khedr, Milad, Evans, Leanne A., Bygott, Helen, Luangrath, Emily, West, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411108/
https://www.ncbi.nlm.nih.gov/pubmed/34485014
http://dx.doi.org/10.1002/jmd2.12225